Clinical trial · Interventional
PEMF and PEC Blocks in Mastectomy Reconstruction Patients
A Comparison of Pulsed Electromagnetic Fields (PEMF) and Pectoral (PEC) Interfascial Blocks on Postoperative Pain Reduction in Patients Undergoing Mastectomy and Tissue Expander Reconstruction
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a prospective randomized controlled double-blind interventional study comparing the effect of pulsed-electromagnetic field device (PEMF), pectoral interfascial block (PIB), and placebo on postoperative pain control. This study has the interdisciplinary cooperation of the regional anesthesia group, and the breast and plastic surgery divisions. All female patients with breast cancer evaluated at Columbia University Medical Center (CUMC) who are undergoing unilateral or bilateral mastectomy with tissue expander reconstruction will be offered enrollment in this prospective study.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Female | — | UNRESOLVED | — |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Bupivacaine Hydrochloride | Drug | — | UNRESOLVED |
| Placebo Device | Other | — | UNRESOLVED |
| Placebo Drug | Other | — | UNRESOLVED |
| Pulsed Electromagnetic Field (PEMF) Device | Device | — | UNRESOLVED |
| Ropivacaine Hydrochloride | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- OTHER
- label
- Active PEMF + Treatment PIB
- description
- Participants will receive an active device (Pulsed Electromagnetic Field (PEMF) Device) and active drug (Bupivacaine Hydrochloride or Ropivacaine HCl).
- interventionNames
- Drug: Bupivacaine Hydrochloride
- Device: Pulsed Electromagnetic Field (PEMF) Device
- Drug: Ropivacaine Hydrochloride
- type
- OTHER
- label
- Active PEMF + Sham PIB
- description
- Participants will receive an active device (Pulsed Electromagnetic Field (PEMF) Device) and placebo drug.
- interventionNames
- Other: Placebo Drug
- Device: Pulsed Electromagnetic Field (PEMF) Device
- type
- OTHER
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Subjects must be female * Subjects must be 18 years or older * Subjects must be undergoing unilateral or bilateral mastectomy with tissue expander reconstruction Exclusion Criteria: * Allergy to all narcotic medications * Intake of any chronic opioids or pain medications preoperatively for a chronic condition or chronic use.
References
Publications (0)
Data not yet available